Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q4 2025 Earnings Call Transcript February 12, 2026
Vertex Pharmaceuticals Incorporated misses on earnings expectations. Reported EPS is $5.03 EPS, expectations were $5.11.
Operator: Good day, and welcome to the Vertex Pharmaceuticals Incorporated Fourth Quarter 2025 Earnings Call. All participants will be in a listen-only mode. After today’s presentation, there will be an opportunity to ask questions. Please note this event is being recorded....
